Colorado BioScience Association

Congratulations to Founder & CEO, Rose Nash, PhD, and the team at Biota Inc. on the opening of your new 7,500-square-foot laboratory and innovation facility in Longmont.

The new facility will support continued development, validation, and commercialization of Biota’s PFAS monitoring platforms, as well as growth of its scientific and engineering team in Colorado.

"Biota represents the science-driven innovation that defines Colorado's life sciences leadership," said Elyse Blazevich, President and CEO of Colorado BioScience Association. "Their work developing faster and more scalable PFAS monitoring technologies demonstrates how Colorado companies transform breakthrough science into solutions that save and change lives in our state and around the world."

We look forward to your continued success!

Read more: https://www.prnewswire.com/news-releases/colorado-pfas-testing-company-biota-opens-longmont-innovation-facility-amid-growing-demand-for-faster-forever-chemical-monitoring-302789626.html

Colorado PFAS Testing Company Biota Opens Longmont Innovation Facility Amid Growing Demand for Faster "Forever Chemical" Monitoring /PRNewswire/ -- As states, utilities, and environmental teams face growing pressure to monitor and respond to PFAS contamination, Colorado-based environmental...

Member Success: Colorado BioScience Association congratulates CBSA member companies Biota Inc., Codebreaker Labs, GenesisTissue Inc., and Intero Biosystems on receiving Advanced Industries Accelerator Grants from the Colorado Office of Economic Development and International Trade.

We also applaud innovators from CBSA’s partner academic and research institutions, including University of Colorado Boulder, University of Colorado Denver, and Colorado School of Mines, who received grant funding to advance promising technologies.

Colorado’s Advanced Industries Accelerator Grant Program continues to deliver powerful results for innovation and economic growth. Since inception, the program has awarded $188.1 million, helped generate $4.3 billion in follow-on capital, and delivered an impressive $22.08 return for every $1 invested.

Strategic state investments strengthen Colorado’s competitiveness by supporting the R&D-intensive industries driving our economy and advancing solutions that save and change lives. Congratulations to all grantees!

Colorado's Advanced Industries Accelerator Program Supports 36 Recipients Developing Cutting-Edge Technologies | Colorado Office of Economic Development and International Trade DENVER - Today, the Global Bus

Last week, CBSA members, staff, and lobbyists met with Colorado Attorney General and gubernatorial candidate Phil Weiser. This valuable touchpoint before the primary election with AG Weiser included discussions about the impact of life sciences across Colorado and allowed CBSA members to share perspectives on key issues affecting innovation, healthcare, workforce, and economic growth in our state.

The meeting was also a critical opportunity for CBSA members to share concerns about the artificial intelligence bill recently passed by Colorado’s General Assembly. AG Weiser indicated that, whether he continues as Attorney General or is elected Colorado’s next governor, he wants to do what he can to make sure some of those concerns are addressed during the upcoming rulemaking process.

Shown in Photo:

Meg Porfido - Phil Weiser for Colorado
Amy Berenbaum Goodman, JD, MBE - Vice President and Counsel, Policy + Advocacy, CBSA
Amy Friedman - Community Engagement Lead, Phil Weiser for Colorado

Row 2:
Elyse Blazevich - President & CEO, CBSA
Rita “Ruta” Sanzgiri, Ph.D. - Intellectual Property Attorney, CBSA Board Secretary and Community Growth & Engagement Committee Chair
Matthew Teter - Vice President of Partnerships, CBSA

Row 3:
Byron Hewett - Life Sciences Executive & Strategic Advisor, CBSA Board Chair
Jenny Nikaido - Community & State Government Relations Sr. Specialist, Terumo Blood and Cell Technologies
Jason Tejani - SVP, Head of Legal, Enveda

Row 4:
Zoey Powers - Senior Director, State Government Affairs, Eli Lilly and Company
Melanie Layton - Co-Owner, Lobbyist, Colorado Legislative Strategies
Robin Harper Cowie - Chief Financial Officer, Biodesix, Inc., CBSA Board Vice Chair

Row 5:
Nate Myszka - Director, State Government Affairs, Medtronic
Caroline Woodhouse - Lobbyist, Colorado Legislative Strategies
Phil Weiser - Colorado Attorney General & Gubernatorial Candidate

Colorado BioScience Association congratulates the 2026 Class of Boettcher Investigators!

Each of the eight scientists will receive a $250,000 grant through the Boettcher Foundation’s Webb-Waring Biomedical Research Awards Program to fund up to three years of independent scientific research, with total grant funding reaching $2 million.

This year’s class represents the next generation of scientific excellence and marks another milestone in Boettcher Foundation’s 17-year commitment to strengthening Colorado’s biomedical research ecosystem. The Webb-Waring Biomedical Research Awards provide critical early-career support and position recipients to compete for additional private, state, and federal research funding while helping Colorado retain top scientific talent. Meet the 2026 Class of Boettcher Investigators (Shown L-R):

COLORADO STATE UNIVERSITY
Casey M. Gries, Ph.D
R. Adam Harris, D.V.M., Ph.D., Diplomate ACVP

NATIONAL JEWISH HEALTH
Chen-Shan (Julia) Woodcock, Ph.D.

UNIVERSITY OF COLORADO ANSCHUTZ
Alessandra Brambati, Ph.D.
John Janetzko, Ph.D.
Katherine Kissler, C.N.M., Ph.D.
Kentaro Yomogida, M.D.
UNIVERSITY OF COLORADO BOULDER
Matthew Olm, Ph.D.

“Colorado’s future as a leading hub for health innovation depends on bold scientific thinking and sustained investment in emerging researchers,” said Elyse Blazevich, president and CEO of Colorado BioScience Association. “The Boettcher Investigators are advancing high-impact discoveries across some of the most urgent challenges in human health while strengthening Colorado’s position as a center for biomedical research and innovation. These awards help accelerate breakthrough science, support exceptional talent, and reinforce the collaborative research environment that sets Colorado apart.”

More: https://cobioscience.com/boettcher-foundation-awards-2-million-to-advance-the-groundbreaking-research-of-early-career-scientists/